The Wessex Technology Support Programme (TSP) has issued a call for therapeutic or management solutions for urological disorders.
The call seeks companies that are working in this area and have an innovation that’s not currently in use in the NHS which they want to trial in an NHS setting.
An estimated three to six million people experience some degree of urinary incontinence. Poorly managed urinary leakage can have a substantial physical and psychosocial impact, negatively influencing quality of life and causing major disruption to daily activities increasing risk of falls, increasing likelihood of care home admission and comes with significant personal and systemic costs.
Incontinence often constitutes a long-term condition that requires effective, discreet, reusable and easy-to-use management solutions. The Wessex Academic Health Science Network is seeking innovative approaches of managing incontinence whilst reducing or combating infection and other harms associated with invasive medical devices (e.g. vaginal mesh or indwelling urinary catheters).
Areas of interest to the NHS are improved urinary catheter design, new devices for bladder control that reduce the need for surgery, innovative containment devices as well as preventative technologies that maintain pelvic floor strength or facilitate bladder/bowel muscle training. The innovation may include new materials, technologies or practices that address antimicrobial resistance.
Interested companies that meet the scope and eligibility criteria can apply by 4pm on 29th January, with shortlisted applications notified by 1st February.
